Physician profile
Beatrix K Edmonds
NPI 1366550196
$9,024.19
in general payments reported to CMS, 2019-2025
38 companies · $1,262 in 2025
The $1,262 reported for 2025 was more than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $986 · 2020: $891 · 2021: $1,280 · 2022: $1,722 · 2023: $1,364 · 2024: $1,518 · 2025: $1,262.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,974 · Education: $171.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,973.68 |
| Education | $171.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,332.18 | 2019-2025 | Rinvoq, Skyrizi |
| Janssen Biotech, INC. | $943.74 | 2019-2025 | Tremfya |
| E.R. Squibb & Sons, L.L.C. | $627.37 | 2022-2025 | Sotyktu |
| Genzyme Corporation | $537.88 | 2019-2025 | |
| Amgen INC. | $482.16 | 2020-2025 | Otezla, Enbrel, Otezla |
| Sun Pharmaceutical Industries INC. | $472.65 | 2019-2024 | |
| Leo Pharma INC. | $376.21 | 2019-2023 | Adbry |
| Galderma Laboratories, L.P. | $363.77 | 2019-2025 | Nemluvio, Aklief, Dysport |
| Lilly USA, LLC | $295.91 | 2019-2025 | Taltz, Olumiant, Ebglyss |
| Vyne Pharmaceuticals INC. | $269.63 | 2020-2021 | |
| Incyte Corporation | $268.93 | 2021-2025 | Opzelura |
| Pfizer INC. | $264.70 | 2019-2025 | |
| Arcutis Biotherapeutics, INC. | $247.17 | 2023-2025 | Zoryve |
| Janssen Scientific Affairs, LLC | $236.16 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $220.79 | 2019-2025 |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Beatrix Edmonds listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.